Main Article Content
Drug-resistant epilepsy is defined by the International League Against Epilepsy as “Failure of adequate trials of two tolerated, appropriately chosen and used antiepileptic drug schedules (whether as monotherapies or in combination) to achieve sustained seizure freedom”. Resistance to epileptic drugs may affect around 30% of patients. This means that more than 20 million people worldwide may face significant consequences (sudden unexpected death in epilepsy, increased risk of injuries, or learning and developmental disabilities at school age). That is why, a continuous search for drugs targeting novel antiseizure mechanisms and alternative ways of epilepsy management is going on. This book covers a number of valid issues aimed at understanding the etiology and pathophysiology of epilepsy, epilepsy genetics, current therapeutic challenges, and possible novel therapeutic targets. The authors point to a number of etiologic factors, for instance acquired (stroke, trauma, infections of the central nervous system) or genetic (missense, nonsense mutations, DNA deletion or duplication, and others). Metabolic or immune factors have been also considered. The involvement of hippocampal sclerosis in the process of epileptogenesis is shown as a key factor in the generation of epileptic brain conditions. CONTINUE READING…..
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Copyright of individual chapters belongs to the respective authors. The authors grant unrestricted publishing and distribution rights to the publisher. The electronic versions of the chapters are published under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0). Users are allowed to share and adapt the chapters for any non-commercial purposes as long as the authors and the publisher are explicitly identified and properly acknowledged as the original source. The books in their entirety are subject to copyright by the publisher. The reproduction, modification, republication and display of the books in their entirety, in any form, by anyone, for commercial purposes are strictly prohibited without the written consent of the publisher.